首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Hev b 5 and Hev b 13 as allergen markers to estimate the allergenic potency of latex gloves.
【24h】

Hev b 5 and Hev b 13 as allergen markers to estimate the allergenic potency of latex gloves.

机译:Hev b 5和Hev b 13作为变应原标记,可估计乳胶手套的变应原效力。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Sensitization to natural rubber latex has been linked to proteins from medical latex gloves. Various assays to estimate the amount of residual allergenic proteins extractable from latex gloves to assess their potential exposure hazard have inherent weaknesses. OBJECTIVE: This investigation was aimed at developing 2-site immunoenzymetric assays and identifying appropriate protein markers to assess the allergenic potential of latex gloves. METHODS: The presence of 6 latex allergens-Hev b 1, 2, 3, 5, 6, and 13-was measured in a cross-section of commercial latex medical gloves by using monoclonal and polyclonal antibody-based 2-site immunoenzymetric assays. The overall allergenic potential of these gloves was assessed by IgE-inhibition assay. Stepwise multiple regression analyses were performed to identify marker allergens that best explained the variation in latex glove allergenicity. RESULTS: All 6 latex allergens were detected in at least some of the glove samples. Hev b 5 and Hev b 13 were identified as the marker allergens that combined best to explain the variation in the glove allergenicity. The significant multiple correlation (R=0.855) between these 2 markers and glove allergenic potency forms the basis of an assay to gauge latex glove allergenicity. CONCLUSION: The overall allergenic potential of latex gloves can be estimated by using Hev b 5 and Hev b 13 as indicator allergens. The correlation between glove allergenicity and the level of these allergens was maintained for low-protein gloves (<200 microg/g). This estimation of glove allergenicity was superior to that obtained by using total protein readings.
机译:背景:对天然橡胶胶乳的敏化作用已与医用胶乳手套中的蛋白质联系在一起。各种测定法可估计可从乳胶手套提取的残留致敏蛋白的量,以评估其潜在的暴露危害,这些方法具有固有的弱点。目的:本研究旨在开发2-位点免疫酶分析法,并确定合适的蛋白质标记物以评估乳胶手套的致敏潜力。方法:通过使用基于单克隆和多克隆抗体的2位免疫酶分析法,在商用乳胶医用手套的横截面中测量了6种乳胶过敏原-Hev b 1、2、3、5、6和13的存在。这些手套的总体过敏原潜力通过IgE抑制试验评估。进行逐步多元回归分析,以找出最能解释乳胶手套过敏性变化的标志物过敏原。结果:在至少一些手套样本中检测到所有6种乳胶过敏原。已鉴定出Hev b 5和Hev b 13是标记过敏原,它们结合得最好,可以解释手套过敏原的变化。这两个标记物与手套的过敏原效力之间的显着多重相关性(R = 0.855)构成了测定乳胶手套过敏原性的测定基础。结论:乳胶手套的总体致敏潜力可以通过使用Hev b 5和Hev b 13作为指示性过敏原来估计。对于低蛋白手套(<200 microg / g),手套的过敏性与这些过敏原水平之间的相关性得以维持。手套过敏原性的这种估计优于通过使用总蛋白质读数获得的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号